A particulate complex for administering nucleic acid into a cell
CA 2407515 A1 · Owner: Biovector Therapeutics (S.A.) · Inventors: Kravtzoff, Roger; De Miguel, Ignacio; Von Hoegen, Paul
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A particulate complex is provided comprising a particulate complex comprising a nucleic acid and a biodegradable cationized polyhydroxylated molecule wherein the polyhydroxylated molecule has a charge up to approximately 1.0 meq/g.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 24, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 24, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 24, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.